![](https://webarchive.library.unt.edu/eot2008/20090511032637im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20090511032637im_/http://www.cancer.gov/images/spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20090511032637im_/http://www.cancer.gov/images/spacer.gif)
| Procedimiento usado para reemplazar la médula ósea destruida por un tratamiento de dosis altas de medicamentos contra el cáncer o por radiación. El trasplante puede ser autólogo (la médula de la misma persona tomada antes del tratamiento), alogénico (médula donada por otra persona) o singenéico (médula donada por un gemelo idéntico). |
![](https://webarchive.library.unt.edu/eot2008/20090511032637im_/http://www.cancer.gov/images/spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20090511032637im_/http://www.cancer.gov/images/gray_spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20090511032637im_/http://www.cancer.gov/images/spacer.gif)
|
![](https://webarchive.library.unt.edu/eot2008/20090511032637im_/http://www.cancer.gov/images/spacer.gif) |